Ardelyx Inc.

190 articles with Ardelyx Inc.

• Ardelyx To Report First Quarter 2016 Financial Results On May 9, 2016

  5/3/2016

• Ardelyx Reports Fourth Quarter and Full-Year 2015 Financial Results

  3/4/2016

• Ardelyx To Report Fourth Quarter And Full Year 2015 Financial Results On March 4th, 2016

  2/25/2016

• Ardelyx To Present At The 2016 Leerink Partners Global Healthcare Conference

  2/3/2016

• Ardelyx Announces Closing Of Public Offering Including Exercise Of Underwriters' Right To Purchase Additional Shares

  1/14/2016

• Ardelyx Announces Pricing Of Public Offering Of Common Stock

  1/8/2016

• Ardelyx Announces Proposed Public Offering Of Common Stock

  1/7/2016

• Ardelyx Reports Positive Clinical Results Of RDX022 For The Treatment Of Hyperkalemia

  1/5/2016

• Ardelyx Strengthens Executive Leadership Team With The Appointment Of Paul Korner, MD, MBA, As Executive Vice President And Chief Medical Officer

  1/4/2016

• Ardelyx Reports Third Quarter 2015 Financial Results

  11/12/2015

• Ardelyx To Report Third Quarter 2015 Financial Results On November 12, 2015

  10/30/2015

• Ardelyx Announces Upcoming Presentations For Tenapanor At The American Society of Nephrology's Kidney Week Meeting 2015

  10/28/2015

• Ardelyx Appoints William Bertrand, Jr. To Its Board Of Directors

  10/27/2015

• Ardelyx To Present Phase 2 Data For Tenapanor In IBS-C Patients At The 2015 American College of Gastroenterology Annual Meeting

  10/9/2015

• Sanofi Terminates a $200 Million NaP2b Development Deal With Ardelyx

  9/3/2015

• Ardelyx Reports Second Quarter 2015 Financial Results

  8/12/2015

• Ardelyx To Report Second Quarter 2015 Financial Results On August 12, 2015

  8/6/2015

• Ardelyx To Present At The 2015 Wedbush PacGrow Healthcare Conference

  8/5/2015

• Ardelyx To Provide Updates On Research And Development Programs At Today's Inaugural R&D Day In New York City

  7/14/2015

• Ardelyx To Host Inaugural R&D Investor Day In New York City On July 14, 2015

  6/30/2015